Verdane has made a strategic investment in Clue, the leading women's health app, to enhance growth and innovation in addressing underserved health needs.

Investment Overview

On January 15, 2026, Clue, the premier women-led app for period and cycle tracking, announced a significant investment from Verdane, a distinguished European growth equity firm dedicated to technology-driven businesses. This strategic investment is the largest in Clue's history and represents a pivotal milestone as Verdane becomes the principal investor in the app, which boasts over 100 million downloads globally.

The funding stems from Verdane's €2 billion growth fund and will bolster Clue’s ambitious pursuit of long-term profitability following a prosperous 2025. The partnership with Verdane aims to enhance Clue’s growth trajectory through initiatives such as product innovation, global market expansion, personalized healthcare access, and the advancement of data privacy and security measures.

Industry Overview

The women's health and wellness sector is an increasingly vital area within the global health landscape, particularly as awareness grows regarding the unique healthcare needs of women. In many markets, women represent the